Artemis Medicare Services Ltd
- Market Cap ₹ 3,783 Cr.
- Current Price ₹ 239
- High / Low ₹ 306 / 208
- Stock P/E 38.2
- Book Value ₹ 55.8
- Dividend Yield 0.19 %
- ROCE 14.6 %
- ROE 12.9 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 33.0% CAGR over last 5 years
Cons
- Stock is trading at 4.29 times its book value
- Promoter holding has decreased over last quarter: -8.14%
- Company has a low return on equity of 11.7% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|
| 547 | 565 | 408 | 555 | 737 | 879 | 937 | 1,042 | |
| 481 | 503 | 373 | 487 | 643 | 746 | 785 | 869 | |
| Operating Profit | 66 | 62 | 35 | 68 | 94 | 133 | 152 | 172 |
| OPM % | 12% | 11% | 9% | 12% | 13% | 15% | 16% | 17% |
| 2 | 4 | 7 | 3 | 7 | 7 | 33 | 31 | |
| Interest | 11 | 13 | 13 | 12 | 20 | 31 | 32 | 29 |
| Depreciation | 20 | 23 | 22 | 22 | 31 | 40 | 45 | 47 |
| Profit before tax | 37 | 31 | 8 | 37 | 51 | 68 | 108 | 128 |
| Tax % | 45% | 36% | 18% | 16% | 25% | 28% | 24% | |
| 20 | 19 | 6 | 31 | 38 | 49 | 82 | 96 | |
| EPS in Rs | 0.97 | 1.49 | 0.49 | 2.40 | 2.88 | 3.62 | 6.00 | 6.77 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 16% | 12% | 7% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 19% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 33% |
| 3 Years: | 37% |
| TTM: | 34% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 56% |
| 3 Years: | 52% |
| 1 Year: | -8% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 12% |
| Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 13 | 13 | 13 | 13 | 14 | 14 | 14 |
| Reserves | 280 | 300 | 307 | 346 | 390 | 435 | 824 | 869 |
| 114 | 113 | 147 | 201 | 286 | 320 | 290 | 279 | |
| 147 | 160 | 133 | 149 | 216 | 203 | 229 | 264 | |
| Total Liabilities | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 | 1,426 |
| 381 | 393 | 383 | 489 | 605 | 719 | 745 | 794 | |
| CWIP | 49 | 56 | 81 | 64 | 95 | 33 | 40 | 35 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 124 | 137 | 136 | 157 | 205 | 219 | 572 | 597 | |
| Total Assets | 554 | 586 | 600 | 710 | 905 | 972 | 1,357 | 1,426 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| 40 | 56 | 27 | 60 | 127 | 109 | 146 | |
| -50 | -26 | -37 | -107 | -158 | -88 | -385 | |
| 14 | -27 | 18 | 44 | 38 | -29 | 267 | |
| Net Cash Flow | 5 | 2 | 8 | -3 | 7 | -8 | 27 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 52 | 49 | 49 | 48 | 46 | 39 | 39 |
| Inventory Days | |||||||
| Days Payable | |||||||
| Cash Conversion Cycle | 52 | 49 | 49 | 48 | 46 | 39 | 39 |
| Working Capital Days | -51 | -36 | -36 | -26 | -43 | -27 | -28 |
| ROCE % | 10% | 4% | 10% | 11% | 14% | 15% |
Documents
Announcements
-
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
12 Feb - Delhi HC (Jan 28, 2026) dismissed RPFC writ; CGIT order spared company ₹3.92 crore PF deposit
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 Feb - Transcript of Earnings Conference Call - Q3 and 9M FY26
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
3 Feb - Audio recording of Q3 and 9M FY26 earnings conference call available (Feb 3, 2026) on company website.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 3 Feb
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
2 Feb - Monitoring agency reports no deviations; ₹330 crore preferential issue, ₹62.27 crore used, ₹267.73 crore unutilized (Dec 31, 2025).
Annual reports
Concalls
-
Feb 2026Transcript PPT REC
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptAI SummaryPPT
-
May 2025TranscriptAI SummaryPPT
-
Feb 2025TranscriptAI SummaryPPT
-
Nov 2024TranscriptAI SummaryPPT
-
Aug 2024TranscriptAI SummaryPPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Feb 2024TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023TranscriptAI SummaryPPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023TranscriptAI SummaryPPT
-
Nov 2022TranscriptAI SummaryPPT
Business Profile[1]
Promoted by Apollo Tyres Group, Artemis Medicare Services Ltd manages multi-specialty hospitals in Haryana under the brand Artemis Hospitals. The company provides a comprehensive range of advanced medical and surgical services across specialties such as cardiology, oncology, orthopedics, neurology, nephrology, gastroenterology, and critical care.